Commercial Production of Transgenic Crops Genetically Engineered to Produce Pharmaceuticals

Lon Crosby;

Publication

Article

April 15, 2003

BioPharm International

BioPharm International-04-01-2003

Volume16

Issue 4

Commercial Production of Transgenic Crops Genetically Engineered to Produce Pharmaceuticals

Author(s):

Lon Crosby

by Lon Crosby Farmers may be the pharmaceutical producers of the 21st Century. The technology exists, and practices commonly used in agriculture can be modified to meet envisioned GMPs ? and those modifications are within reach.

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue

Virus Inactivation in the 1990s and into the 21st Century

Using Peptide Maps as Identity and Purity Tests for Lot Release Testing of Recombinant Therapeutic Proteins

Getting Ready for Risk-Based GMPs

GMP Issues: Breaking Ground

Guest Editorial: Benchmarking Biotech

Optimized Nutrient Additives for Fed-Batch Cultures

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Commercial Production of Transgenic Crops Genetically Engineered to Produce Pharmaceuticals

Newsletter